---
figid: PMC7576355__OTT-13-10499-g0001
figtitle: Androgen regulation of cell cycle and CDK4/6 pathway
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC7576355
filename: OTT-13-10499-g0001.jpg
figlink: pmc/articles/PMC7576355/figure/f0001/
number: F1
caption: Androgen regulation of cell cycle and CDK4/6 pathway. Genomic AR signaling
  activates androgen response elements (ARE) to promote cell proliferation. Non-genomic
  AR signaling acts via membrane bound AR and activated cytosolic AR by activating
  PI3K/AKT, Src, Ras/Raf, and PKC to regulate MAPK/ERK activating ELK1 transcription
  factor to promote cell proliferation. Non-MAPK/ERK-dependent AR signaling includes
  membrane bound AR increasing intracellular calcium activating PKA and transcription
  factors (TF) to also promote cell proliferation. PI3K/AKT activates mTOR which leads
  to increase cyclin D1, in addition, PI3K/AKT phosphorylates the transcription factor
  FOXO1 which causes cytosolic degradation preventing FOXO1’s tumor suppressor effects.
  Cytosolic AR also down-regulates p21 and p27, cyclin-dependent kinase inhibitors
  that negatively regulate cell cycle progression. Cyclin D1 activates CDK4/6 which
  leads to phosphorylation of the hypo-phosphorylated active Rb, generating a hyper-phosphorylated
  inactive Rb state. When Rb is hyper-phosphorylated, the activating transcription
  factor E2F is released and enters the nucleus to promote transition from G1 (pre-DNA
  synthesis) to S phase (DNA synthesis). CDK4/6 inhibitors block this pathway by preventing
  phosphorylation of Rb, thereby keeping Rb in its active tumor suppressor state,
  and not allowing the activating E2F to be released to enter the nucleus.
papertitle: Novel Therapeutic Strategies for CDK4/6 Inhibitors in Metastatic Castrate-Resistant
  Prostate Cancer.
reftext: Adam M Kase, et al. Onco Targets Ther. 2020;13:10499-10513.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.911065
figid_alias: PMC7576355__F1
figtype: Figure
redirect_from: /figures/PMC7576355__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7576355__OTT-13-10499-g0001.html
  '@type': Dataset
  description: Androgen regulation of cell cycle and CDK4/6 pathway. Genomic AR signaling
    activates androgen response elements (ARE) to promote cell proliferation. Non-genomic
    AR signaling acts via membrane bound AR and activated cytosolic AR by activating
    PI3K/AKT, Src, Ras/Raf, and PKC to regulate MAPK/ERK activating ELK1 transcription
    factor to promote cell proliferation. Non-MAPK/ERK-dependent AR signaling includes
    membrane bound AR increasing intracellular calcium activating PKA and transcription
    factors (TF) to also promote cell proliferation. PI3K/AKT activates mTOR which
    leads to increase cyclin D1, in addition, PI3K/AKT phosphorylates the transcription
    factor FOXO1 which causes cytosolic degradation preventing FOXO1’s tumor suppressor
    effects. Cytosolic AR also down-regulates p21 and p27, cyclin-dependent kinase
    inhibitors that negatively regulate cell cycle progression. Cyclin D1 activates
    CDK4/6 which leads to phosphorylation of the hypo-phosphorylated active Rb, generating
    a hyper-phosphorylated inactive Rb state. When Rb is hyper-phosphorylated, the
    activating transcription factor E2F is released and enters the nucleus to promote
    transition from G1 (pre-DNA synthesis) to S phase (DNA synthesis). CDK4/6 inhibitors
    block this pathway by preventing phosphorylation of Rb, thereby keeping Rb in
    its active tumor suppressor state, and not allowing the activating E2F to be released
    to enter the nucleus.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Immt
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Cdk4
  - Ar
  - Cdk6
  - Cdk2
  - Akt1
  - Pik3r1
  - Mtor
  - Src
  - Metap2
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Gabrg2
  - Ephb2
  - Mapk1
  - Eif2ak3
  - Lamp1
  - Alpha-re
  - Elk1
  - Kcnh8
  - CDKL1
  - CDKL2
  - CDKL3
  - CDKL4
  - CDKL5
  - CDK3
  - CDK4
  - CDK5
  - CDK6
  - CDK7
  - CDK8
  - CDK9
  - CDK10
  - CDK11A
  - CDK11B
  - CDK12
  - CDK13
  - CDK14
  - CDK15
  - CDK16
  - CDK17
  - CDK18
  - CDK19
  - CDK20
  - CDK1
  - CDK2
  - IMMT
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - AR
  - CCNE1
  - CCNE2
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - SRC
  - FGR
  - FYN
  - YES1
  - CD33
  - STXBP1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - WARS1
  - EPHB2
  - MAPK1
  - MAPK3
  - EIF2AK3
  - TF
  - ELK1
  - KCNH4
  - KCNH8
  - PRKAR1A
  - PRKAR1B
  - PRKAR2A
  - PRKAR2B
  - PRKACA
  - PRKACB
  - PRKACG
  - rb
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - DCTN6-p27
  - dap
  - CG9588
  - ebi
  - E2f2
  - E2f1
  - ar
  - CycE
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Tor
  - Src42A
  - Csk
  - Src64B
  - und
  - tral
  - glo
  - Ras64B
  - Ras85D
  - Raf
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - LanB2
  - anon-70Db
  - ca
  - anon-70Dc
  - Erk7
  - rl
  - PEK
  - tf
  - Pka-C1
  - Pka-R2
  - Pka-C3
  - Pka-R1
  - Pka-C2
  - DHT DHT
  - Ca
  - OHT OHT
  - DHT
  - Diarrhea
---
